Vera Therapeutics Vera logo

News Releases

May 27, 2021

Vera Therapeutics to Participate in the Jefferies Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that management will … Read more
May 13, 2021

Vera Therapeutics Announces Pricing of Initial Public Offering

SOUTH SAN FRANCISCO, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (“Vera”), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the pricing of its initial … Read more
April 20, 2021

Vera Therapeutics Appoints Industry Veteran Dr. Celia Lin as Chief Medical Officer

Announces two senior appointments to product development and manufacturing and finance teams   SOUTH SAN FRANCISCO, Calif.,   April 20, 2021  – Vera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with … Read more
January 19, 2021

Vera Therapeutics Launches with $80 Million Series C Financing to Develop Phase 2b Novel Biologic for Kidney Disease

Potential first-in-class disease-modifying biologic in late-stage clinical studies Experienced executive development team from Gilead Sciences   SOUTH SAN FRANCISCO, Calif.,  January 19, 2021 – Vera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for … Read more
Top